Related Experiment Video

Updated: Sep 4, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

p53 status and the efficacy of cancer therapy in vivo

S W Lowe1, S Bodis, A McClatchey

  • 1Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139.

Science (New York, N.Y.)
|November 4, 1994
PubMed

Insights

The p53 tumor suppressor gene is crucial for cancer treatment response. Tumors lacking p53 are resistant to therapies like radiation and adriamycin, highlighting p53

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • The p53 tumor suppressor gene plays a critical role in cellular responses to DNA damage.
  • Understanding the role of p53 in therapeutic resistance is essential for developing effective cancer treatments.

Purpose of the Study:

  • To investigate the impact of p53 gene status on tumor responsiveness to genotoxic therapies.
  • To determine if p53 deficiency leads to acquired resistance and relapse.

Main Methods:

  • Comparison of therapeutic responsiveness in genetically defined mouse tumor models (p53-expressing vs. p53-deficient).
  • Treatment with gamma radiation and adriamycin.
  • Assessment of apoptosis and tumor growth.
  • Analysis of acquired p53 mutations.

Main Results:

  • p53-expressing tumors showed high apoptosis and regression after treatment.
  • p53-deficient tumors exhibited resistance, continued enlargement, and low apoptosis.
  • Acquired p53 mutations correlated with treatment resistance and relapse in initially p53-expressing tumors.

Conclusions:

  • Inactivation of the p53 gene leads to apoptosis defects, resulting in treatment-resistant tumors.
  • p53 status is a significant determinant of tumor response to radiation and adriamycin therapy.
  • Targeting p53 pathways may overcome therapeutic resistance.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...